C or D Rating

This telecommunications company’s dip in free cash flow and 2013 dividend cut raise questions, but a smart acquisition gives its dividend new hope.

BCE’s 2008 dividend cuts may have tarnished its track record, but in 2019, this company can wipe the slate clean.

This financial services company pays a strong 6.5% yield… but is it safe?

Pfizer’s struggles with free cash flow and dividend cuts may have a silver lining if its growth meets expectations.

When it comes to safety and reliability, this company doesn’t have the greatest reputation. And its dividend may soon be equally tarnished.

This pharmaceutical company is hoping history repeats itself – but it likely won’t.

When a company has to borrow money to pay its dividend, that’s not a good sign.

It may be one of the largest master limited partnerships in the U.S., but its dividend isn’t looking good…

This REIT can currently cover its dividend, but if its funds from operations decline, it could be in jeopardy.

This financial institution can afford its dividend as it stands today… but we predict a cut in the future.